BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261105T120000
DTEND;TZID=America/New_York:20261105T160000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:PICB: Advance Your Biotech With NCI SBIR Funding and Resources
DESCRIPTION:Are you aware of the federal funding program that supports the commercialization of efforts of biotech innovators? The Small Business Innovation Research (SBIR) program at the National Cancer Institute (NCI) provides over $200 million annually in funding to small businesses developing innovative cancer technologies. \n\nAs part of NCI”s engine of innovation for advancing novel cancer-related technologies from lab to market\, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent\, diagnose\, and treat cancer. \n\nThe in-person seminar will be held from 12:00 pm to 1:30 pm\, followed by the 1:1 meetings from 1:30 pm to 4:00 pm. The program will cover funding opportunities for oncology startups\, academic spinout companies\, and early-stage academic entrepreneurs\, as well as tips for writing competitive grant proposals and commercialization resources for applicants and awardees. \n\nRegister here: https://luma.com/xl004qet\n\nSpeakers\nJulianne Twomey\, PhD\, joined the NCI Small Business Innovation Research (SBIR) Development Center as a program director in January 2025. She manages a portfolio of small businesses focused on developing anticancer therapeutics.  \n\nMing Zhao\, PhD\, is a program director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center\, In this role\, he develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics\, molecular diagnostics\, medical imaging\, radiotherapy\, and AI-aided technology development. \n\nAfter the presentation\, participants will have the opportunity to engage in 1:1 20-minute meetings with NCI SBIR Program Directors Julianne Twomey\, PhD\, and Ming Zhao\, PhD\, to discuss their cancer technology projects and potential fit with NCI SBIR/STTR funding opportunities. Come with prepared questions\, a pitch deck or specific aims page on your technology. Pre-registration is a must\; limited spots available. Register here: https://bookings.cloud.microsoft/book/MeettheNCISBIRProgramDirectors11BioLabs@nih.onmicrosoft.com/?ismsaljsauthenabled=&utm_source=luma
X-ALT-DESC;FMTTYPE=text/html:Are you aware of the federal funding program that supports the commercialization of efforts of biotech innovators? The Small Business Innovation Research (SBIR) program at the National Cancer Institute (NCI) provides over $200 million annually in funding to small businesses developing innovative cancer technologies. \n\nAs part of NCI”s engine of innovation for advancing novel cancer-related technologies from lab to market\, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent\, diagnose\, and treat cancer. \n\nThe in-person seminar will be held from 12:00 pm to 1:30 pm\, followed by the 1:1 meetings from 1:30 pm to 4:00 pm. The program will cover funding opportunities for oncology startups\, academic spinout companies\, and early-stage academic entrepreneurs\, as well as tips for writing competitive grant proposals and commercialization resources for applicants and awardees. \n\nRegister here: https://luma.com/xl004qet\n\nSpeakers\nJulianne Twomey\, PhD\, joined the NCI Small Business Innovation Research (SBIR) Development Center as a program director in January 2025. She manages a portfolio of small businesses focused on developing anticancer therapeutics.  \n\nMing Zhao\, PhD\, is a program director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center\, In this role\, he develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics\, molecular diagnostics\, medical imaging\, radiotherapy\, and AI-aided technology development. \n\nAfter the presentation\, participants will have the opportunity to engage in 1:1 20-minute meetings with NCI SBIR Program Directors Julianne Twomey\, PhD\, and Ming Zhao\, PhD\, to discuss their cancer technology projects and potential fit with NCI SBIR/STTR funding opportunities. Come with prepared questions\, a pitch deck or specific aims page on your technology. Pre-registration is a must\; limited spots available. Register here: https://bookings.cloud.microsoft/book/MeettheNCISBIRProgramDirectors11BioLabs@nih.onmicrosoft.com/?ismsaljsauthenabled=&utm_source=luma
LOCATION:303A College Road East Princeton NJ 08540
UID:e.3317.1667251
SEQUENCE:3
DTSTAMP:20261027T150002Z
URL:https://princetonmercerregionalchamberofcommerce.growthzoneapp.com/chamber-events/Details/picb-advance-your-biotech-with-nci-sbir-funding-and-resources-1965263?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR